Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DOVA

Dova Pharmaceuticals (DOVA) Stock Price, News & Analysis

Dova Pharmaceuticals logo

About Dova Pharmaceuticals Stock (NASDAQ:DOVA)

Advanced Chart

Key Stats

Today's Range
$28.04
$28.04
50-Day Range
$28.04
$28.04
52-Week Range
$5.62
$28.54
Volume
35,036 shs
Average Volume
499,313 shs
Market Capitalization
$807.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DOVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dova Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

DOVA Stock News Headlines

Lifelines Ahead
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Fulcrum swings back up after FDA lifts clinical hold
See More Headlines

DOVA Stock Analysis - Frequently Asked Questions

Dova Pharmaceuticals Inc (NASDAQ:DOVA) announced its quarterly earnings data on Tuesday, August, 6th. The company reported ($0.60) EPS for the quarter, missing analysts' consensus estimates of ($0.57) by $0.03. The firm earned $3.52 million during the quarter, compared to analyst estimates of $5.63 million. Dova Pharmaceuticals had a negative net margin of 544.09% and a negative trailing twelve-month return on equity of 101.60%.

Dova Pharmaceuticals (DOVA) raised $66 million in an initial public offering on Thursday, June 29th 2017. The company issued 4,100,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan, Jefferies and Leerink Partners acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Dova Pharmaceuticals investors own include Global Blood Therapeutics (GBT), Aldeyra Therapeutics (ALDX), Allena Pharmaceuticals (ALNA), Fate Therapeutics (FATE), Fibrocell Science (FCSC), Tesaro (TSRO) and Viking Therapeutics (VKTX).

Company Calendar

Last Earnings
8/06/2019
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:DOVA
CIK
1685071
Fax
N/A
Employees
115
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.60)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$72.28 million
Net Margins
-544.09%
Pretax Margin
N/A
Return on Equity
-101.60%
Return on Assets
-67.21%

Debt

Debt-to-Equity Ratio
0.41
Current Ratio
5.64
Quick Ratio
5.37

Sales & Book Value

Annual Sales
$10.35 million
Price / Sales
78.02
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.71 per share
Price / Book
10.35

Miscellaneous

Outstanding Shares
28,800,000
Free Float
N/A
Market Cap
$807.55 million
Optionable
Optionable
Beta
2.74
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:DOVA) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners